Rankings
▼
Calendar
DAWN Q4 2020 Earnings — Day One Biopharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
DAWN
Day One Biopharmaceuticals, Inc.
$2B
Q4 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$6M
Net Income
-$34M
EPS (Diluted)
$-0.56
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$6M
Free Cash Flow
-$6M
Stock-Based Comp.
$350,000
Balance Sheet
Total Assets
$46M
Total Liabilities
$94M
Stockholders' Equity
-$54M
Cash & Equivalents
$44M
← FY 2020
All Quarters
Q1 2021 →
